⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for hht

Every month we try and update this database with for hht cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Pharmacokinetic (PK) Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic TumorsNCT00675350
Hematologic Tum...
Omacetaxine
18 Years - Teva Branded Pharmaceutical Products R&D, Inc.
Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene MutationNCT00375219
Chronic Myeloid...
Omacetaxine mep...
18 Years - Teva Branded Pharmaceutical Products R&D, Inc.
Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous LeukemiaNCT00003239
Leukemia
Recombinant Int...
Cytarabine
Omacetaxine Mep...
12 Years - M.D. Anderson Cancer Center
Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene MutationNCT00375219
Chronic Myeloid...
Omacetaxine mep...
18 Years - Teva Branded Pharmaceutical Products R&D, Inc.
Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CMLNCT00462943
Chronic Myeloid...
Omacetaxine mep...
18 Years - Teva Branded Pharmaceutical Products R&D, Inc.
Pharmacokinetic (PK) Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic TumorsNCT00675350
Hematologic Tum...
Omacetaxine
18 Years - Teva Branded Pharmaceutical Products R&D, Inc.
Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous LeukemiaNCT00003239
Leukemia
Recombinant Int...
Cytarabine
Omacetaxine Mep...
12 Years - M.D. Anderson Cancer Center
Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CMLNCT00462943
Chronic Myeloid...
Omacetaxine mep...
18 Years - Teva Branded Pharmaceutical Products R&D, Inc.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: